Marietta Investment Partners’s Dr. Reddy's Laboratories RDY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-17,300
Closed -$273K 164
2024
Q4
$273K Sell
17,300
-8,550
-33% -$128K 0.06% 142
2024
Q3
$411K Hold
25,850
0.09% 127
2024
Q2
$394K Sell
25,850
-10,900
-30% -$156K 0.09% 129
2024
Q1
$539K Buy
36,750
+21,400
+139% +$312K 0.12% 114
2023
Q4
$214K Hold
15,350
0.05% 154
2023
Q3
$205K Buy
+15,350
New +$208K 0.06% 158

Other funds holding RDY

Marietta Investment Partners's RDY Position: Q1 2025 in Review

Marietta Investment Partners sold out of Dr. Reddy's Laboratories (RDY) in Q1 2025, closing a stake of 17,300 shares — an estimated $273K sold.

Marietta Investment Partners first reported a position in RDY in Q3 2023 and held it in 6 quarters. The position peaked at $539K in Q1 2024. 244 funds tracked by Wall St. Rank hold RDY as of Q1 2025.

  • Marietta Investment Partners reported no remaining Dr. Reddy's Laboratories position as of Q1 2025 after selling out during the quarter.
  • Marietta Investment Partners sold 17,300 Dr. Reddy's Laboratories shares in Q1 2025, an estimated $273K.
  • Marietta Investment Partners first reported a position in Dr. Reddy's Laboratories in Q3 2023 and held it in 6 quarters.
  • Marietta Investment Partners's Dr. Reddy's Laboratories position peaked at $539K in Q1 2024.
  • 244 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q1 2025.

Based on Marietta Investment Partners's 13F filing for Q1 2025, filed 7 May 2025.